Silencing of PHD1 has been shown to prevent p53 activation upon chemotherapy in different CRC cell lines, thereby inhibiting DNA repair and favoring cell death (Deschoemaeker et al. 2015). The gene discussed is TP53; the disease is colorectal carcinoma.